Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Andrew Gregory Health editor

MS patients in England to benefit from major roll out of take-at-home pill

Hand holding a pill
The tablet needs to be taken only 20 times in a four-year cycle. Photograph: Charlotte Ball/PA

Thousands of patients with multiple sclerosis (MS) in England are to become the first in Europe to benefit from a major roll out of an immunotherapy pill.

Current treatments involve regular trips to hospital, drug infusions, frequent injections and extensive monitoring, which add to the burden on patients and healthcare systems.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.